Home/Filings/4/0001209191-18-032563
4//SEC Filing

Miller Vincent A. 4

Accession 0001209191-18-032563

CIK 0001488613other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:06 PM ET

Size

8.7 KB

Accession

0001209191-18-032563

Insider Transaction Report

Form 4
Period: 2018-05-21
Miller Vincent A.
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2018-05-21$85.00/sh1,570$133,45070,088 total
  • Exercise/Conversion

    Common Stock

    2018-05-21$29.94/sh+1,570$47,00671,658 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-05-211,5700 total
    Exercise: $29.94Exp: 2024-04-09Common Stock (1,570 underlying)
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
  • [F2]This stock option was granted on April 9, 2014 and vested in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018.

Issuer

Foundation Medicine, Inc.

CIK 0001488613

Entity typeother

Related Parties

1
  • filerCIK 0001584999

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:06 PM ET
Size
8.7 KB